Speaker illustration

Doctor Tomoyuki Nagai

Kyoto Prefectural University of Medicine, Kyoto (Japan)

Management of doxorubicin-induced cardiomyopathy as the adverse event of chemotherapy in acute critical decompensated heart failure: a case report.

Event: ESC Congress 2022

Topic: Cardio-Oncology

Session: Cardio-oncology – Cancer treatment and cardiovascular toxicity


ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb